FARALLON CAPITAL MANAGEMENT LLC Q4 2020 Filing

Filed February 16, 2021

Portfolio Value

$15.4B

Holdings

131

Report Date

Q4 2020

Filing Type

13F-HR

All Holdings (131 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	QUREUNIQURE NV	300,000	$10.8B	70.52%
102	—CASCADE ACQUISITION CORP	990,000	$10.3B	67.31%
103	—KINNATE BIOPHARMA INC	250,000	$9.9B	64.70%
104	BDQMALBIREO PHARMA INC	250,000	$9.4B	61.02%
105	SURFUSDSURFACE ONCOLOGY INC	1,000,000	$9.2B	60.12%
106	GOSS 5 06/01/27GOSSAMER BIO INC	10,000,000	$9.0B	58.76%
107	—ACACIA COMMUNICATIONS INC	100,000	$7.3B	47.47%
108	—FIVE PRIME THERAPEUTICS INC	400,000	$6.8B	44.27%
109	COGTCOGENT BIOSCIENCES INC	600,000	$6.7B	43.84%
110	IMGNEURIMMUNOGEN INC	1,000,000	$6.5B	41.97%
111	—RADIUS HEALTH INC	6,783,000	$6.0B	39.00%
112	MRVLMARVELL TECHNOLOGY GROUP LTD	125,000	$5.9B	38.67%	Call
113	—CURIS INC	725,000	$5.9B	38.63%
114	APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC	3,522,000	$5.9B	38.58%
115	STTKSHATTUCK LABS INC	100,000	$5.2B	34.10%
116	OPHTEURIVERIC BIO INC	754,740	$5.2B	33.93%
117	TGTXTG THERAPEUTICS INC	100,000	$5.2B	33.85%
118	ARWRARROWHEAD PHARMACEUTICALS IN	67,600	$5.2B	33.75%
119	YB4PSAVARA INC	4,452,086	$5.1B	33.31%
120	—HUMANCO ACQUISITION CORP	400,000	$4.4B	28.68%
121	MASS908 DEVICES INC	75,000	$4.3B	27.79%
122	FDMT4D MOLECULAR THERAPEUTICS IN	100,000	$4.1B	26.97%
123	KURAKURA ONCOLOGY INC	125,000	$4.1B	26.56%
124	EQEQUILLIUM INC	700,000	$3.7B	24.37%
125	—ISIS PHARMACEUTICALS INC DEL	2,500,000	$2.7B	17.78%
126	NVLSEURALPINE IMMUNE SCIENCES INC	200,000	$2.5B	16.40%
127	IVAINVENTIVA SA	160,000	$2.3B	15.09%
128	SPRYSILVERBACK THERAPEUTICS INC	47,620	$2.2B	14.36%
129	—BROADMARK RLTY CAP INC	7,174,613	$1.9B	12.60%
130	GOLGBPGOL LINHAS AEREAS INTELIGENT	85,838	$843.0M	5.48%
131	—CEREVEL THERAPEUTICS HLDNG I	134,175	$758.0M	4.93%

PreviousPage 2 of 2